Yunnan Botanee Bio-Technology Group Co.LTD (SHE:300957)
China flag China · Delayed Price · Currency is CNY
33.20
+2.15 (6.92%)
Aug 25, 2026, 3:04 PM CST

SHE:300957 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
545.89505.72503.05756.81,051862.92
Depreciation & Amortization
210.74183.75189.82137.8958.2358.53
Other Amortization
71.1483.8944.4437.2-14.86
Loss (Gain) From Sale of Assets
-4.16-2.575.04-0.46--0.52
Asset Writedown & Restructuring Costs
35.8934.55115.69--0.04
Loss (Gain) From Sale of Investments
-62.35-106.25-99.97-47.12--29.63
Provision & Write-off of Bad Debts
-0.17-2.0112.412.97--
Other Operating Activities
67.4142.23-69.6129.6-340.1217.24
Change in Accounts Receivable
60.89263.42-310.03-348.62--45.1
Change in Inventory
-58.55104.81254.89-121.42--221.43
Change in Accounts Payable
189.08-113.1292.5162.54-490.74
Change in Other Net Operating Assets
-7.11----5.27
Operating Cash Flow
1,024976.6694.87610.44769.451,153
Operating Cash Flow Growth
13.65%40.54%13.83%-20.66%-33.25%167.44%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-104-482.99-378.38-274.28-353.42-270.68
Sale of Property, Plant & Equipment
0.250.313.482.890.010.23
Cash Acquisitions
--0.01-493.5-7.47-6.5
Investment in Securities
-107.1253.85-758.94188.09261.69-2,300
Other Investing Activities
69.5390.749.9158.7580.7118.83
Investing Cash Flow
-141.32-138.13-1,084-518.06-18.49-2,558

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Long-Term Debt Issued
-742.48837.71105.45--
Total Debt Issued
695.32742.48837.71105.45--
Long-Term Debt Repaid
--773.11-388.87-100.64-64.72-42.89
Total Debt Repaid
-761.12-773.11-388.87-100.64-64.72-42.89
Net Debt Issued (Repaid)
-65.81-30.63448.844.81-64.72-42.89
Issuance of Common Stock
-----2,905
Repurchase of Common Stock
---124.88-109.84--
Common Dividends Paid
-285.94-265.64-262.52-339.14-254.16-190.62
Other Financing Activities
-111.54-0.76-8.97-14.3-0.78-7.58
Financing Cash Flow
-463.29-297.0352.47-458.47-319.662,664

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
-11.95-2.1-1.23-0.720.03-0
Net Cash Flow
406.97539.34-337.82-366.81431.321,258

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
919.53493.61316.48336.16416.02882.04
Free Cash Flow Growth
219.73%55.97%-5.85%-19.20%-52.83%158.23%
Free Cash Flow Margin
16.48%9.21%5.52%5.87%8.30%21.93%
Free Cash Flow Per Share
2.191.170.760.800.982.17
Levered Free Cash Flow
805.3279.491.1770.0330.36612.5
Unlevered Free Cash Flow
809.31290.83102.1673.1333.33615.12

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Income Tax Paid
595.43593.45673.76652.43616.71490.75
Change in Working Capital
159.14237.29-6-316.43-229.26